Health Condition 1: A150- Tuberculosis of lung
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed smear positive drug sensitive pulmonary tuberculosis patients who have at least one sputum smear samples positive for tubercle bacilli (at least 1+) by auramine rhodamine staining- Patients willing to come for regular followup
Exclusion criteria
Exclusion criteria: -Patient with HIV -Patients diagnosed with Chronic Kidney disease and Chronic liver disease requiring dose modifications. -Pregnant and lactating women. -Newly diagnosed tuberculosis patients with respiratory failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the proportion of patients achieving sputum smear conversion at the end of 1 month between oral Curcuma longa as an add on therapy to standard anti tuberculosis treatment and placebo with standard anti tuberculosis treatment in newly diagnosed drug sensitive pulmonary tuberculosis patientsTimepoint: 0, 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare adverse eventsTimepoint: 0, 1 month, 2 months, 6 months;to compare the change in inflammatory markersTimepoint: 0, 1 month;to compare treatment cureTimepoint: 0, 6 months | — |
Countries
India
Contacts
Jawarhalal Institute of Post - Graduate Medical Education and Research